Announces Unsuccessful Phase 3 Trial for Blood Cancer Drug
tipranks.com/news/abbvie-abbv-announces-unsuccessful-phase-3-trial-for-blood-cancer-drugEarlier today, drugmaker AbbVie ($ABBV) announced that its Phase 3 trial for a blood cancer treatment using venetoclax, which was developed with Ro...
This story appeared on tipranks.com, 2025-06-16 19:20:00.